• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Angiogenesis promotion by fixing biotinylated VFGF on endothelial cells

Research Project

Project/Area Number 13671459
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeSingle-year Grants
Section一般
Research Field Cerebral neurosurgery
Research InstitutionDokkyo University School of Medicine

Principal Investigator

HOYA Katsumi  Dokkyo University, School of Medicine, Medical department, lecturer, 医学部, 講師 (60270873)

Co-Investigator(Kenkyū-buntansha) ASAI Akio  Saitama Medical School, Medical department, lecturer, 医学部, 講師 (50231858)
YOSHIMOTO Yuhei  Dokkyo University, School of Medicine, Medical department, professor, 医学部, 教授 (50242061)
Project Period (FY) 2001 – 2002
Project Status Completed (Fiscal Year 2002)
Budget Amount *help
¥2,200,000 (Direct Cost: ¥2,200,000)
Fiscal Year 2002: ¥500,000 (Direct Cost: ¥500,000)
Fiscal Year 2001: ¥1,700,000 (Direct Cost: ¥1,700,000)
Keywordsavidin / endothelium / biotin / VFGF / drug delivery / VEGF
Research Abstract

We have developed an intravascular drug delivery system, in. which a drug injected from a catheter is fixed to the vasculature of the targeted tissue. Cellular protein of viable endothelial cells is first biotinylated directly by biotinylation reagents, and then bound by an avidinated drug or, using avidin as a linker, a biotinylated drug. We hypothesized that if vascular endothelial growth factor (VEGF), which promotes endothelial proliferation and angiogenesis, is biotinylated and given to the endothelium by the above method, its effect will become greater than when the cells are simply exposed to it for very few minutes. In the first experiment, we investigated intracellular locations of the molecule given to the endothelium by the above method. Streptavidht labeled with β-galactosidase was fixed to biotmylated endothelium, and.cells were harvested 0,1,2,3,6,12 hours after. The enzyme was visualized byhistochemical method (x-gal). Electron microscopic study revealed that the enzyme was located at 0 hour in the cytoplasm and reached nuclear membrane. Few were found on the cellular membrane. In the second experiment, biotinylated VEGF was made, and fixed to the biotinylated endothelial cells. Though the activity of the biotinylated VEGF was the same as that of intact VEGF, the fixation of the growth factor on the cells was not so effective for the proliferarion of cultured endothelial cells. We speculate that drugs that influence via the cell membrane receptors are not good candidates for our drug delivery method because the biotinylated drugs enter too fast into the cells without binding to their receptors.

Report

(3 results)
  • 2002 Annual Research Report   Final Research Report Summary
  • 2001 Annual Research Report
  • Research Products

    (1 results)

All Other

All Publications (1 results)

  • [Publications] Hoya K et al.: "A novel intravascular drug delivery method using endothelial biotinylation and avidin-biotin binding."Drug Delivery. 8. 215-222 (2001)

    • Related Report
      2001 Annual Research Report

URL: 

Published: 2001-04-01   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi